The authors propose increased use of single-use technologies in biopharmaceutical manufacturing to achieve operational excellence without compromising product quality.
Detelv Szarafinksi
Advertisement
Detelv Szarafinksi is global program manager of FlexACT at Sartorius Stedim Biotech GmbH in Goettingen, Germany.
Articles by Detelv Szarafinksi
Advertisement
Latest Updated Articles
A Detail View of Single-Use Equipment OpportunitiesPublished: March 1st 2010 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Building Resilience in Pharma: Our Top 10 Questions from CPHI Frankfurt
2
Everything to Know About Pharmaceutical Tariffs in 2025
3
New Dosage Forms and Delivery Systems Driving 505(b)(2) Success
4
Behind the Headlines Episode 28: Navigating FDA Shakeups and Obesity Drug Wars
5
